MiR‐122 was also found to be positively correlating (r) with BMI (GC: 0.25; IC: 0.19), AST (GC: 0.46; IC: 0.36), ALT (GC: 0.45; IC: 0.69), and CK18 (GC: 0.31; IC: 0.23), thus suggesting its efficacy in NAFLD grading. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.